NICE has published an update to NICE Guideline (NG) 71 on Parkinson’s disease in adults.
Parkinson’s disease is one of the most common neurological conditions. It is estimated to affect up to 160 people per 100,000, with an annual incidence in the UK of 15–20 per 100,000. There is no consistently reliable test that can distinguish Parkinson’s disease from other conditions that have a similar clinical presentation. The diagnosis is primarily based on a clinical history and examination.
The July 2017 update of NG71, provides new recommendations on:
- first-line treatment for managing motor symptoms
- adjuvant treatment of motor symptoms
- managing and monitoring impulse control disorders as an adverse effect of dopaminergic therapy
- pharmacological management of non-motor symptoms (e.g. daytime sleepiness, psychotic symptoms)
- deep brain stimulation
- palliative care.